查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1869825

影像生物标记市场规模、份额和趋势分析报告：按生物标记、成像技术、应用、最终用途、地区和细分市场预测（2025-2033 年）

Imaging Biomarkers Market Size, Share & Trends Analysis Report By Biomarkers (Molecular/Nuclear Biomarkers, Quantitative Imaging Biomarkers), By Imaging Technology, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

影像生物标誌物市场摘要

2024年全球影像生物标记市场规模估计为139.5亿美元，预计2033年将达到392.3亿美元。

预计从 2025 年到 2033 年，该市场将以 12.62% 的复合年增长率成长。这一市场成长归因于癌症、神经系统疾病和心血管疾病等慢性疾病负担的加重。

随着对精准、非侵入性诊断方法和疾病早期检测的需求日益增长，影像生物标记的临床意义也日益凸显。此外，精准医疗和病患分层的日益普及，也强化了影像生物标记在治疗决策和临床试验设计中的作用。美国FDA和欧洲药品管理局（EMA）等监管机构的支持性监管倡议，以及影像生物标记合格流程的完善，都增强了业界的信心。同时，公共和私人机构对转化影像研究的投资，也推动了学术界和产业界在发现、检验和标准化方面的努力。

当前的市场动态凸显了创新和整合的活跃时期。 2025年，罗氏的Elexis PRO-C3检测获得FDA核准，用于测量肝纤维化；赛默飞世尔科技和罗氏诊断则透过伴随诊断测试扩展了其癌症生物标记产品组合。诸如Eurofins Scientific收购西班牙SynLab诊断业务等策略性收购，预示着生物标记服务网路化的趋势。赛默飞世尔科技与英国生物银行合作，与科技开发人员共同进行大规模生物标记和生物资讯检验及资料整合工作。

技术进步不断重塑市场格局。新型混合影像系统（PET/CT、PET/MRI）、高特异性放射性追踪剂、人工智慧和放射组学等技术，使得定量影像生物标记（QIB）的开发成为可能，从而能够对疾病状态进行客观且可重复的测量。标准化的成像通讯协定和云端基础的分析平台正在提高实验室间的可重复性，这对于符合监管要求和进行多中心试验至关重要。

近年来，由于分子诊断技术的显着进步，影像生物标记产业持续成长。 2025年3月，Cizzle Biotech推出了CIZ1B生物标记检测，这是一种用于早期肺癌检测的非侵入性血液检测。此检测透过识别高风险患者，实现早期疗育并优化诊断流程，进而与CT和PET扫描等影像诊断检测形成互补。与iGenomeDX的合作将在美国提供可扩展的准入环境，提高检测的可及性，并支持分子生物标记和影像生物标记的联合应用。

2024年8月，日立高新技术公司与Gencurix公司合作，开发基于生物标记发现的数位癌症分子诊断测试。该计划旨在将分子层面的知识与影像数据结合，从而实现更精准的诊断和治疗方案，助力个人化医疗的实现。这两项进展标誌着分子和影像生物标记融合的趋势，透过提高诊断准确性、加速药物研发进程和促进疾病早期发现，推动市场成长。这些进展巩固了采用更全面的生物标记方法的趋势，未来的持续发展将推动市场走向创新、临床应用和长期成长。

儘管报销和标准化方面仍存在挑战，但影像技术与资料科学和分子诊断的融合正使影像生物标记成为诊断、药物研发和个人化治疗的关键组成部分。对基于人工智慧的定量分析和已通过核准的影像结果的进一步投资将支持预测期内市场的持续扩张。

目录

第一章调查方法和范围

第二章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL 分析
    • 新冠疫情影响分析

4. 影像生物标记市场：生物标记业务分析

  • 细分仪表板
  • 全球影像生物标记市场：按生物标记分類的差异分析
  • 全球影像生物标记市场规模及趋势分析（依生物标记划分，2021-2033年）
  • 解剖学生物标誌物
  • 功能性生物标记
  • 分子/核生物标记物
  • 定量成像生物标记
  • 其他的

5. 成像生物标记市场：成像技术业务分析

  • 细分仪表板
  • 全球影像生物标记市场：按成像技术分類的差异分析
  • 全球影像生物标记市场规模及趋势分析（依成像技术划分），2021-2033年
  • MRI
  • CT
  • 宠物
  • SPECT
  • 超音波
  • 其他的

6. 影像生物标记市场：应用业务分析

  • 细分仪表板
  • 全球影像生物标记市场：按应用领域分類的差异分析
  • 全球影像生物标记市场规模及应用趋势分析（2021-2033年）
  • 诊断
  • 药物发现与开发
  • 个人化医疗
  • 疾病风险评估
  • 其他的

7. 影像生物标记市场：终端用户业务分析

  • 细分仪表板
  • 全球影像生物标记市场：按最终用途分類的差异分析
  • 全球影像生物标记市场规模及趋势分析（依最终用途划分，2021-2033年）
  • 医院
  • 诊断/影像中心
  • 製药和生物技术公司
  • 其他的

8. 影像生物标记市场：按生物标记、成像技术、应用和最终用途分類的区域估算和趋势分析

  • 区域仪錶板
  • 市场规模、预测与趋势分析，2021-2033年
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 参与企业
  • 策略规划
  • 2023年企业市场分析
  • 参与企业概况
    • Siemens Healthineers
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc.
    • Siemens Healthineers AG
    • QIAGEN
    • Bio-Rad Laboratories, Inc.
    • PerkinElmer Inc.
    • Brainomix
    • IXICO plc
    • Median Technologies
Product Code: GVR-4-68040-792-5

Imaging Biomarkers Market Summary

The global imaging biomarkers market size was estimated at USD 13.95 billion in 2024 and is projected to reach USD 39.23 billion by 2033, growing at a CAGR of 12.62% from 2025 to 2033. The growth of the market can be attributed to the increasing burden of chronic diseases such as cancer, neurological disorders, and cardiovascular conditions.

The need for precise, non-invasive diagnostic methods and early disease detection has elevated the clinical relevance of imaging biomarkers. Furthermore, the growing emphasis on precision medicine and patient stratification has reinforced their role in therapeutic decision-making and clinical trial design. Supportive regulatory developments from agencies such as the U.S. FDA and EMA, which are advancing qualification pathways for imaging biomarkers, are enhancing industry confidence. Concurrently, public-private investments in translational imaging research are strengthening discovery, validation, and standardization initiatives across academic and industrial settings.

The current market dynamics emphasize upon an active period of innovation and consolidation. In 2025, Roche was granted FDA approval over its Elecsys PRO-C3 test to measure liver fibrosis and Thermo Fisher Scientific and Roche Diagnostics enlarged their biomarker cancer portfolios with companion diagnostic assays. Such strategic takeovers like the one of Eurofins Scientific to acquire the diagnostic activities of Synlab in Spain show a sense of move towards a networked biomarker services. Thermo Fisher has collaborated with UK Biobank in partnerships with technology developers to undertake massive validation and data integration of biomarkers and bioinformatics.

The market still continues to be redefined by technological advancement. Novel hybrid imaging systems (PET/CT, PET/MRI), novel high-specificity radiotracers, and artificial intelligence and radiomics are allowing quantitative imaging biomarkers (QIBs), which compose objective, reproducible measurements of disease states. Harmonized imaging protocols and cloud-based analytics platforms are enhancing cross-site reproducibility, which is a requirement to qualify regulation and multicenter trials.

The imaging biomarkers industry is growing in recent years due to the essential advances in molecular diagnostics. Cizzle Biotech introduced CIZ1B biomarker assay in March 2025, which is a non-invasive blood test to detect lung cancer at its early stage. This assay can be used to complement imaging-based diagnostic tests like CT and PET scans by identifying high-risk patients, allowing them to be intervened earlier and enhancing their diagnostic processes. The partnership with iGenomeDX will provide scalable accessibility in the U.S., improving its accessibility and supporting the combination of molecular and imaging biomarkers.

In August 2024, Hitachi High-Tech collaborated with Gencurix to create digital technology-based cancer molecular diagnostic tests with biomarker discovery. This project aids personalized medicine by connecting the molecular knowledge to the imaging data to allow the creation of a more specific diagnosis and treatment plan. These two developments point to the trend of combining molecular and imaging biomarkers which is fueling the growth of the market by enhancing diagnostic accuracy, speeding up the process of drug development and by facilitating earlier detection of the disease. All these developments lend strength to the trends toward the use of a more combined biomarker approach, a trend that ongoing future development has put the market squarely on the road to innovation, clinical integration, and a long-term growth trajectory.

As the issue of reimbursement and standardization continues, the integration of imaging with data science and molecular diagnostics is making imaging biomarkers a key component of the diagnostics, drug development, and personalized therapy. Further investment on AI-based quantification as well as approved imaging outcomes will support sustainable market expansion during the forecast period.

Global Imaging Biomarkers Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global imaging biomarkers market report based on biomarkers, imaging technology,application, end use, and region.

  • Biomarkers Outlook (Revenue, USD Billion, 2021 - 2033)
  • Anatomical biomarkers
  • Functional biomarkers
  • Molecular/Nuclear Biomarkers
  • Quantitative Imaging Biomarkers
  • Others
  • Imaging Technology Outlook (Revenue, USD Billion, 2021 - 2033)
  • MRI
  • CT
  • PET
  • SPECT
  • Ultrasound
  • Others
  • Application Outlook (Revenue, USD Billion, 2021 - 2033)
  • Diagnostics
  • Drug Discovery & Development
  • Personalized Medicine
  • Disease Risk Assessment
  • Others
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospitals
  • Diagnostic/imaging centers
  • Pharmaceutical and Biotech Companies
  • Others
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Biomarkers
    • 1.2.2. Imaging Technology
    • 1.2.3. Application
    • 1.2.4. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising demand for early diagnosis and personalized medicine
      • 3.2.1.2. Advancements in imaging and molecular biomarker technologies
      • 3.2.1.3. Regulatory approvals supporting clinical adoption
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of imaging equipment and diagnostic tests
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Imaging Biomarkers Market: Biomarkers Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Imaging Biomarkers Market Biomarkers Movement Analysis
  • 4.3. Global Imaging Biomarkers Market Size & Trend Analysis, by Biomarkers, 2021 to 2033 (USD Million)
  • 4.4. Anatomical Biomarkers
    • 4.4.1. Global Anatomical Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Functional Biomarkers
    • 4.5.1. Global Functional Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Molecular/Nuclear Biomarkers
    • 4.6.1. Global Molecular/Nuclear Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Quantitative Imaging Biomarkers
    • 4.7.1. Global Quantitative Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Imaging Biomarkers Market: Imaging Technology Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Imaging Biomarkers Market Imaging Technology, Movement Analysis
  • 5.3. Global Imaging Biomarkers Market Size & Trend Analysis, by Imaging Technology, 2021 to 2033 (USD Million)
  • 5.4. MRI
    • 5.4.1. Global MRI Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. CT
    • 5.5.1. Global CT Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. PET
    • 5.6.1. Global PET Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. SPECT
    • 5.7.1. Global SPECT Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Ultrasound
    • 5.8.1. Global Ultrasound Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Imaging Biomarkers Market: Application Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Imaging Biomarkers Market Application Movement Analysis
  • 6.3. Global Imaging Biomarkers Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Diagnostics
    • 6.4.1. Global Diagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Drug Discovery & Development
    • 6.5.1. Global Drug Discovery & Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Personalized Medicine
    • 6.6.1. Global Personalized Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Disease Risk Assessment
    • 6.7.1. Global Disease Risk Assessment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Imaging Biomarkers Market: End Use Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Imaging Biomarkers Market End Use Movement Analysis
  • 7.3. Global Imaging Biomarkers Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Global Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Diagnostic/imaging centers
    • 7.5.1. Global Diagnostic/imaging centers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Pharmaceutical and Biotech Companies
    • 7.6.1. Global Pharmaceutical and Biotech Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Others
    • 7.7.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Imaging Biomarkers Market: Regional Estimates & Trend Analysis by Biomarkers, Imaging Technology, Application & End Use

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 8.3. North America
    • 8.3.1. North America Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. South Korea Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Imaging Biomarkers Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. Participant's Overview
    • 9.4.1. Siemens Healthineers
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Biomarkers Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. F. Hoffmann-La Roche AG
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Biomarkers Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Abbott Laboratories
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Biomarkers Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Thermo Fisher Scientific Inc.
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Biomarkers Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Siemens Healthineers AG
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Biomarkers Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. QIAGEN
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Biomarkers Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Bio-Rad Laboratories, Inc.
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Biomarkers Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. PerkinElmer Inc.
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Biomarkers Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Brainomix
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Biomarkers Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. IXICO plc
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Biomarkers Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Median Technologies
      • 9.4.11.1. Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Biomarkers Benchmarking
      • 9.4.11.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 4 Global imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 5 Global imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 6 Global imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 7 Global imaging biomarkers market, by region, 2021 - 2033 (USD Million)
  • Table 8 North America imaging biomarkers market, by country, 2021 - 2033 (USD Million)
  • Table 9 North America imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 10 North America imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 11 North America imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 12 North America imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 13 U.S. imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 14 U.S. imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 15 U.S. imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 16 U.S. imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 17 Canada imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 18 Canada imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 19 Canada imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 20 Canada imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 21 Mexico imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 22 Mexico imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 23 Mexico imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 24 Mexico imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 25 Europe imaging biomarkers market, by country, 2021 - 2033 (USD Million)
  • Table 26 Europe imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 27 Europe imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 28 Europe imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 29 Europe imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 30 UK imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 31 UK imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 32 UK imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 33 UK imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 34 Germany imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 35 Germany imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 36 Germnay imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 37 Germany imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 38 France imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 39 France imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 40 France imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 41 France imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 42 Italy imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 43 Italy imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 44 Italy imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 45 Italy imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 46 Spain imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 47 Spain imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 48 Spain imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 49 Spain imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Denmark imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 51 Denmark imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 52 Denmark imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 53 Denmark imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Sweden imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 55 Sweden imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 56 Sweden imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 57 Sweden imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 58 Norway imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 59 Norway imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 60 Norway imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 61 Norway imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific imaging biomarkers market, by country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 67 Japan imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 68 Japan imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 69 Japan imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 70 Japan imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 71 China imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 72 China imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 73 China imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 74 China imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 75 India imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 76 India imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 77 India imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 78 India imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 79 Australia imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 80 Australia imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 81 Australia imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 82 Australia imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 83 Thailand imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 84 Thailand imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 85 Thailand imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 86 Thailand imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 87 South Korea imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 88 South Korea imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 89 South Korea imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 90 South Korea imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 91 Latin America imaging biomarkers market, by country, 2021 - 2033 (USD Million)
  • Table 92 Latin America imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 93 Latin America imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 94 Latin America imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 95 Latin America imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 96 Brazil imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 97 Brazil imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 98 Brazil imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 99 Brazil imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 100 Argentina imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 101 Argentina imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 102 Argentina imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 103 Argentina imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa imaging biomarkers market, by country, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 108 Middle East & Africa imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 109 South Africa imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 110 South Africa imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 111 South Africa imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 112 South Africa imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 117 UAE imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 118 UAE imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 119 UAE imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 120 UAE imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait imaging biomarkers market, by biomarkers, 2021 - 2033 (USD Million)
  • Table 122 Kuwait imaging biomarkers market, by imaging technology, 2021 - 2033 (USD Million)
  • Table 123 Kuwait imaging biomarkers market, by application, 2021 - 2033 (USD Million)
  • Table 124 Kuwait imaging biomarkers market, by end use, 2021 - 2033 (USD Million)
  • Table 125 Participant's overview
  • Table 126 Financial performance
  • Table 127 Key companies undergoing expansions
  • Table 128 Key companies undergoing acquisitions
  • Table 129 Key companies undergoing collaborations
  • Table 130 Key companies launching new products
  • Table 131 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Imaging Biomarkers market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Imaging Biomarkers market driver analysis
  • Fig. 12 Imaging Biomarkers market restraint analysis
  • Fig. 13 Imaging Biomarkers market: Porter's analysis
  • Fig. 14 Imaging Biomarkers market: PESTEL analysis
  • Fig. 15 Imaging Biomarkers market: Biomarkers outlook and key takeaways
  • Fig. 16 Imaging Biomarkers market: Biomarkers market share analysis, 2023 - 2033
  • Fig. 17 Global imaging biomarkers by anatomical biomarkers market, 2021 - 2033 (USD Million)
  • Fig. 18 Global imaging biomarkers by functional biomarkers market, 2021 - 2033 (USD Million)
  • Fig. 19 Global imaging biomarkers by molecular/nuclear biomarkers market, 2021 - 2033 (USD Million)
  • Fig. 20 Global imaging biomarkers by quantitative imaging biomarkers market, 2021 - 2033 (USD Million)
  • Fig. 21 Global imaging biomarkers by other market, 2021 - 2033 (USD Million)
  • Fig. 22 Imaging Biomarkers market: Imaging Technology outlook and key takeaways
  • Fig. 23 Imaging Biomarkers market: Imaging Technology market share analysis, 2023-2033
  • Fig. 24 Global imaging biomarkers by therapeutic drug monitoring market, 2021 - 2033 (USD Million)
  • Fig. 25 Global imaging biomarkers by MRI market, 2021 - 2033 (USD Million)
  • Fig. 26 Global imaging biomarkers by CT market, 2021 - 2033 (USD Million)
  • Fig. 27 Global imaging biomarkers by PET market, 2021 - 2033 (USD Million)
  • Fig. 28 Global imaging biomarkers by SPECT market, 2021 - 2033 (USD Million)
  • Fig. 29 Global imaging biomarkers by Ultrasound market, 2021 - 2033 (USD Million)
  • Fig. 30 Global imaging biomarkers by others market, 2021 - 2033 (USD Million)
  • Fig. 31 Imaging Biomarkers market: Application outlook and key takeaways
  • Fig. 32 Imaging Biomarkers market: Application market share analysis, 2023-2033
  • Fig. 33 Global imaging biomarkers by diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 34 Global imaging biomarkers by Drug Discovery & Development market, 2021 - 2033 (USD Million)
  • Fig. 35 Global imaging biomarkers by Personalized Medicine market, 2021 - 2033 (USD Million)
  • Fig. 36 Global imaging biomarkers by Disease Risk Assessment market, 2021 - 2033 (USD Million)
  • Fig. 37 Global imaging biomarkers by others market, 2021 - 2033 (USD Million)
  • Fig. 38 Imaging Biomarkers market: End Use outlook and key takeaways
  • Fig. 39 Imaging Biomarkers market: End Use market share analysis, 2023-2033
  • Fig. 40 Global imaging biomarkers by hospitals market, 2021 - 2033 (USD Million)
  • Fig. 41 Global imaging biomarkers by diagnostics centres market, 2021 - 2033 (USD Million)
  • Fig. 42 Global imaging biomarkers by pharmaceutical and biotech companies market, 2021 - 2033 (USD Million)
  • Fig. 43 Global imaging biomarkers by others market, 2021 - 2033 (USD Million)
  • Fig. 44 Regional marketplace: Key takeaways
  • Fig. 45 North America imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 U.S. imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 47 Canada imaging biomarkers market, 2021 - 2033 (USD Million)
  • Fig. 48 Mexico imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Europe imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 50 UK imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Germany imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 52 France imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 Italy imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Spain imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 55 Denmark imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Sweden imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 57 Norway imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Asia-Pacific imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Japan imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 60 China imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 India imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 62 Australia imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 63 Thailand imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 64 South Korea imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 65 Latin America imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Brazil imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 67 Argentina imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 68 MEA imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 69 South Africa imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 70 Saudi Arabia imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 71 UAE imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 72 Kuwait imaging biomarkers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 73 Key company categorization
  • Fig. 74 Company market positioning
  • Fig. 75 Market participant categorization
  • Fig. 76 Strategy framework